19 Jul Form Bio
Amicia Elliott, Ph.D., Vice President of Product
Oct. 7 | 4:30pm | FLW Ballroom G
Austin, Texas
(Private)
Form Bio is the leading provider of AI/ML-powered in silico solutions that accelerate and de-risk AAV gene therapy development. We deliver data-driven insights into AAV genome integrity to identify risk profiles across the development pipeline—enabling better characterization of candidate vectors. Our proprietary models further optimize safety, efficacy, and manufacturability by enabling smarter decisions earlier in development. Together, these capabilities help teams reduce time, cost, and risk on the path to lead candidate selection.